摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethylpyridin-4-yl] 4-nitrooxybutanoate

中文名称
——
中文别名
——
英文名称
[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethylpyridin-4-yl] 4-nitrooxybutanoate
英文别名
——
[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethylpyridin-4-yl] 4-nitrooxybutanoate化学式
CAS
——
化学式
C20H22N4O7S
mdl
——
分子量
462.5
InChiKey
NYSONPQJTVUIIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    32
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    168
  • 氢给体数:
    1
  • 氢受体数:
    10

文献信息

  • Pharmaceutical compounds
    申请人:Del Soldato Piero
    公开号:US20070197499A1
    公开(公告)日:2007-08-23
    Compounds or their salts of general formula (I): A-B—N(O) s wherein: s is an integer equal to 1 or 2; A=R-T 1 -, wherein R is the drug radical and T 1 =(CO) t or (X) t′ , wherein X═O, S, NR 1c , R 1c is H or a linear or branched alkyl or a free valence, t and t′ are integers and equal to zero or 1, with the proviso that t=1 when t′=0; t=0 when t′=1; B=-T B -X 2 —O—wherein T B =(CO) when t=0, T B =X when t′=0, X being as above defined; X 2 is equal to R 1B—X—R 2B radical wherein X is as above defined, R 1B and R 2B , equal to or different from each other, are linear or branched C 1 -C 6 alkylenes, or X 2 is a radical wherein two alkylene chains C 1 -C 4 are linked to nonadjacent positions of a central ring having 4 or 6 atoms, said ring being an unsaturated cycloaliphatic ring, or a saturated or aromatic heterocylic ring, containing one or two heteroatoms, equal or different, selected from O, S, N; wherein the unsaturated cycloaliphatic ring does not have aromatic character according to Huckel's rule.
    通式(I)的化合物或其盐:A-B-N(O)s其中:s是等于1或2的整数;A = R-T1-,其中R为药物基团,T1 =(CO)或(X)t',其中X = O,S,NR1c,R1c是H或线性或支链烷基或自由价,t和t'是整数,等于零或1,但前提是当t' = 0时,t = 1;当t' = 1时,t = 0;B = -TB-X2-O-,其中TB =(CO)当t = 0时,TB = X当t' = 0时,X如上定义;X2等于R1B-X-R2B基团,其中X如上定义,R1B和R2B相等或不同,是线性或支链C1-C6烷基,或X2是基团,其中两个C1-C4烷基链连接到具有4或6个原子的中心环的非相邻位置,该环是不饱和的环状脂肪族环,或饱和的或芳香的杂环,包含一个或两个异原子,相同或不同,从O,S,N中选择;其中不饱和的环状脂肪族环不具有根据Huckel法则的芳香性质。
  • Pharmaceutical Compounds
    申请人:SOLDATO Piero Del
    公开号:US20090170941A1
    公开(公告)日:2009-07-02
    Compounds or their salts of general formula (I): A-B—N(O) s wherein: s is an integer equal to 1 or 2; A=R-T 1 -, wherein R is the drug radical and T 1 =(CO) t or (X) t′ , wherein X=O, S, NR 1c , R 1c is H or a linear or branched alkyl or a free valence, t and t′ are integers and equal to zero or 1, with the proviso that t=1 when t′=0; t=0 when t′=1; B=-T B -X 2 —O— wherein T B =(CO) when t=0, T B =X when t′=0, X being as above defined; X 2 is equal to R 1B —X—R 2B radical wherein X is as above defined, R 1B and R 2B , equal to or different from each other, are linear or branched C 1 -C 6 alkylenes, or X 2 is a radical wherein two alkylene chains C 1 -C 4 are linked to nonadjacent positions of a central ring having 4 or 6 atoms, said ring being an unsaturated cycloaliphatic ring, or a saturated or aromatic heterocylic ring, containing one or two heteroatoms, equal or different, selected from O, S, N; wherein the unsaturated cycloaliphatic ring does not have aromatic character according to Huckel's rule.
    通式(I)的化合物或其盐:A-B-N(O)s,其中:s是等于1或2的整数;A=R-T1-,其中R是药物基团,T1=(CO)或(X)t′,其中X=O、S、NR1c、R1cis H或线性或支链烷基或自由价,t和t′是整数且等于零或1,但是当t′=0时,t=1;当t′=1时,t=0;B=-TB-X2-O-,其中TB=(CO)当t=0时,TB=X当t′=0时,X如上定义;X2等于R1B-X-R2Bradical,其中X如上定义,R1B和R2B,相等或不同于彼此,是线性或支链C1-C6烷基,或X2是一个基团,其中两个C1-C4烷基链连接到一个中心环的非相邻位置,该环具有4或6个原子,该环是一个不饱和的环状脂肪环,或者是一个含有一个或两个异原子的饱和或芳香族杂环,相同或不同,所选异原子为O、S、N;其中,不饱和的环状脂肪环不具有根据Huckel规则的芳香性。
  • US7186753B1
    申请人:——
    公开号:US7186753B1
    公开(公告)日:2007-03-06
  • US7399878B2
    申请人:——
    公开号:US7399878B2
    公开(公告)日:2008-07-15
  • US7759392B2
    申请人:——
    公开号:US7759392B2
    公开(公告)日:2010-07-20
查看更多